Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Hydroxychloroquine may help delay skin damage in lupus patients.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Careful management of blood thinners is crucial for lupus patients with APS.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Hydroxychloroquine can help treat certain types of hair loss.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Routine monitoring isn't needed for healthy patients on low-dose oral minoxidil, but is advised for those with kidney issues.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.